Home/Filings/4/0000875045-25-000052
4//SEC Filing

Viehbacher Christopher 4

Accession 0000875045-25-000052

CIK 0000875045other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 4:42 PM ET

Size

8.4 KB

Accession

0000875045-25-000052

Insider Transaction Report

Form 4
Period: 2025-12-01
Viehbacher Christopher
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-01+7,04019,847 total
  • Tax Payment

    Common Stock

    2025-12-01$177.78/sh3,404$605,16316,443 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-12-017,0400 total
    Common Stock (7,040 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock.
  • [F2]Each RSU vested on the third anniversary of the grant date of December 1, 2022.

Issuer

BIOGEN INC.

CIK 0000875045

Entity typeother

Related Parties

1
  • filerCIK 0001774478

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 4:42 PM ET
Size
8.4 KB